Most discontinued anti-tau antibodies (red) targeted tau’s N-terminus. Of the antibodies currently in trials (green), bepranemab and E2814 presented results at CTAD, while JJ-63733657/posdinemab and ...

Taking Out OGA. The rationale behind small-molecule OGA inhibition is that these drugs will decrease tau hyperphosphorylation and aggregation into neurofibrillary tangles (right). [Courtesy of Eli ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

November is Alzheimer's Awareness Month and 7 News met Grand Island couple Tom and Michele Drabik, who shared their experience with the disease.

As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...

The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.

Loneliness has been increasingly linked to heart attacks, strokes and other poor health outcomes, and now a new study shows ...

SEC adopts EDGAR Next - As outlined in this October 22 Cooley alert, the Securities and Exchange Commission (SEC) adopted final ...

dementia and inflammatory diseases such as rheumatoid arthritis. Over the years, many Lilly global drug development teams have been led by LCCP scientists. About Magnol.AI ™ Lilly is redefining the ...

PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, ...

Loneliness increases risk of dementia, cognitive impairment . The study, published in the journal Nature Mental Health in October, pooled 608,561 individuals across 21 population ...